tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders StocksTop Gainers/ Losers/ Active StocksMost Visited WebsitesDividend StocksAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by Upside
New
Top ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
New
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Pro Newsletters
Smart Investor
Popular
Research Tools
Stock ScreenerETF Screener
Popular
Trending StocksDaily Analyst RatingsCompare StocksCompare ETFsPenny Stock ScreenerTechnical Analysis ScreenerDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Education
Personal FinanceHow To Use TipRanksTipRanks LabsWebinar CenterGlossaryFAQs
About Us
About TipRanksContact UsCareersReviewsMobile APP
Working with TipRanks
Enterprise SolutionsTop Online BrokersBecome an Affiliate
Follow Us
NewsTrendingPortfolio
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Notification Center
Top ETFs
Top Smart Score Stocks
Popular
Earnings
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Plans & Pricing
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders Stocks
Top Gainers/ Losers/ Active Stocks
Most Visited Websites
Dividend Stocks
AI Stocks
Largest Companies by Market Cap
ETFs
ETF Center
Top ETFs by Upside
New
Top ETFs by Smart Score
Top Gainers/ Losers/ Active ETFs
Options
Options Market Overview
Unusual Options Activity
Popular
Most Active Options
Options Volume Leaders
Commodities
Gold
New
Crypto
Crypto Center
Bitcoin
Popular
Ethereum
Currency
Currency Center
EUR/USD
Pro Newsletters
Smart Investor
Popular
Research Tools
Stock Screener
ETF Screener
Popular
Trending Stocks
Daily Analyst Ratings
Compare Stocks
Compare ETFs
Penny Stock Screener
Technical Analysis Screener
Daily Insider Trading Tracker
Calendars
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Economic Indicators
Economic Indicators Center
Inflation Rate
Unemployment Rate
Federal Funds Rate
Calculators
Dividend Calculator
Dividend Yield Calculator
Options Profit Calculator
Dollar Cost Averaging
New
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
News
Portfolio
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Calculators
Compound Interest Calculator
New
Mortgage Calculator
Popular
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Enterprise Solutions
Education
How To Use TipRanks
TipRanks Labs
Webinar Center
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
Follow Us

CYBN Stock Latest News

Cybin Completes Share Consolidation; Maintains Ownership Ratios
Company AnnouncementsCybin Completes Share Consolidation; Maintains Ownership Ratios
6h ago
CYBN
Cybin Inc. CEO to Speak at Global Investment Conference
PremiumCompany Announcements
Cybin Inc. CEO to Speak at Global Investment Conference
15d ago
CYBN
Cybin Inc. Shareholders Approve Key Decisions
PremiumCompany Announcements
Cybin Inc. Shareholders Approve Key Decisions
23d ago
CYBN
Cybin Prepares for Phase 3 Trial of Depression Treatment
PremiumCompany Announcements
Cybin Prepares for Phase 3 Trial of Depression Treatment
1M ago
CYBN
Cybin realigns governance, nominating and compensation committees
PremiumThe Fly
Cybin realigns governance, nominating and compensation committees
1M ago
CYBN
Cybin completes FDA Type B initial breakthrough meeting D
PremiumThe FlyCybin completes FDA Type B initial breakthrough meeting D
1M ago
CYBN
Scientific journal retracts three papers on MDMA-assisted therapy, NYT reports
Premium
The Fly
Scientific journal retracts three papers on MDMA-assisted therapy, NYT reports
1M ago
ATAI
CMPS
Lykos psychedelic treatment for PTSD rejected by FDA
Premium
The Fly
Lykos psychedelic treatment for PTSD rejected by FDA
1M ago
ATAI
CMPS
Cybin reports Q2 net loss C$15M vs. C$15M last year
PremiumThe Fly
Cybin reports Q2 net loss C$15M vs. C$15M last year
1M ago
CYBN
Cybin Inc. Advances Neuropsychiatric Drug Development
PremiumCompany Announcements
Cybin Inc. Advances Neuropsychiatric Drug Development
1M ago
CYBN
Cybin Inc. Engages at Canaccord Genuity Growth Conference
PremiumCompany Announcements
Cybin Inc. Engages at Canaccord Genuity Growth Conference
1M ago
CYBN
Cybin price target lowered to $3 from $4 at TD Cowen
PremiumThe Fly
Cybin price target lowered to $3 from $4 at TD Cowen
3M ago
CYBN
Here’s What You Missed in Cannabis, Psychedelics This Week
PremiumThe FlyHere’s What You Missed in Cannabis, Psychedelics This Week
3M ago
ACB
CGC
Cybin Advances Mental Health Treatments
Premium
Company Announcements
Cybin Advances Mental Health Treatments
3M ago
CYBN
Cybin Inc. CEO to Speak at Neuro Conference
Premium
Company Announcements
Cybin Inc. CEO to Speak at Neuro Conference
3M ago
CYBN
Cybin Inc. Welcomes New Clinical Development VP
PremiumCompany Announcements
Cybin Inc. Welcomes New Clinical Development VP
3M ago
CYBN
Jefferies sees raised uncertainty around psychedelic approvability after panel
PremiumThe Fly
Jefferies sees raised uncertainty around psychedelic approvability after panel
4M ago
ATAI
CMPS
Mind Medicine sinks after FDA panel votes down Lykos psychedelic drug
PremiumThe Fly
Mind Medicine sinks after FDA panel votes down Lykos psychedelic drug
4M ago
ATAI
CMPS
FDA to Decide on MDMA Therapy for PTSD
PremiumMarket News
FDA to Decide on MDMA Therapy for PTSD
4M ago
ABBV
ATAI
Cybin Spearheads Psychedelic Research Advancements
PremiumCompany AnnouncementsCybin Spearheads Psychedelic Research Advancements
4M ago
CYBN
Cybin Inc. CEO to Speak at Healthcare Showcase
Premium
Company Announcements
Cybin Inc. CEO to Speak at Healthcare Showcase
4M ago
CYBN
Cybin Inc. Advances Psychedelic Treatments for Mental Health
Premium
Company Announcements
Cybin Inc. Advances Psychedelic Treatments for Mental Health
5M ago
CYBN

Trending

Name
Price
Price Change
SPX
S&P 500
DJIA
Dow Jones
NDX
Nasdaq 100
More Trending Stocks >